Who We Are: Alnylam's Core Values
Our core values represent the heart of Alnylam's culture and how we work together to serve the best interests of patients and our communities. Watch this video to hear employees explain what our core values - Commitment to People, Innovation & Discovery, Sense of Urgency, Open Culture, and Passion for Excellence - mean to them and all of us. Want to learn more about our careers and our culture? Visit http://www.alnylam.com/careers/.

▶︎
Alnylam & RNAi Therapeutics: Making our Medicines

▶︎
One family’s journey with hereditary TTR amyloidosis: Dan and Diana

▶︎
RNAi, vielversprechendes Potenzial für eine neue Klasse von Medikamenten

▶︎
Get to Know Alnylam - The Leader in RNAi Therapeutics

▶︎
The Coyle Family Story - Living with Hereditary ATTR (hATTR) amyloidosis

▶︎
A Message from Alnylam CEO Yvonne Greenstreet - Reflecting on 2025 and Looking forward to 2026

▶︎
What is RNAi and How Do RNAi-based Medicines Work?

▶︎
Stephanie, Atteinte de PHA

▶︎
Alnylam Announces $250 Million Expansion of U.S. RNAi Therapeutics Manufacturing Facility

▶︎
David, living with Hereditary ATTR (hATTR) amyloidosis

▶︎
RNAi Therapeutics - How this New Class of Medicines Works

▶︎
Alnylam & RNAi Therapeutics: Silencing Disease. Amplifying Life.

▶︎
Alnylam's siRELIS(TM) Enzymatic Ligation Platform

▶︎
RNA Interference- Come funziona questa nuova tecnologia

▶︎
